Audion Therapeutics BV, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The company’s hearing loss small molecule drug discovery program focuses on inner hair cell regeneration. Its IP portfolio includes new molecules, delivery systems, and drug discovery tools for hearing and hearing loss research. The company was founded in 2008 and is based in Amsterdam, the Netherlands.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Support-Venture GmbH is a private company headquartered in Switzerland. The firm provides management, scientific and technical consulting services.

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Children's Hospital of Pittsburgh provides health care services to infants, children and young adults. It is specialized in cardiology, cardiothoracic surgery, critical care medicine, diabetes, hematology/oncology, neurosurgery, organ & tissue transplantation, orthopedics, otolaryngology and pediatric surgery. The company was founded in 1890 and is headquartered in Pittsburgh, PA

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Part of Bristol Myers Squibb Co., Aventis Research & Technologies GmbH & Co. KG is a company headquartered in Frankfurt, Germany, focused on noncommercial research organizations. On January 07, 2002 Phylos, Inc., a subsidiary of Bristol Myers Squibb Co. since March 2004, acquired Aventis Research & Technologies GmbH & Co. KG from Aventis SA.

Cilian is an emerging biotechnology company developing and marketing a novel expression system. The Company uses a species of Ciliates, a eukaryotic single-cell organism, for the production of enzymes and therapeutic proteins. While Ciliates secrete a number of therapeutically relevant enzymes with high expression rates by nature, recombinant proteins are produced by Ciliates using genetically modified cells. Leveraging the unique capabilities of the Ciliates, the Company aims to produce proteins at an unmatched quality and price, thereby fulfilling its mission to improve human health by facilitating access to biopharmaceuticals.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Jiangsu Wicks Medical Technology Co., Ltd., established on 2015-03-04, Business scope includes medical device research and development,Production,Sales,technical consulting,cosmetic(Does not contain chemical products)research and development,Production,Sales,technical consulting,disinfectant(Free of Hazardous Chemicals)research and development,Sales,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of sterile equipment;Production of disinfection products for the prevention and control of infectious diseases;Disinfection equipment sales;Veterinary drug business;Veterinary drug production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

Bofu--Ipsen (Tianjin) Pharmaceutical Co., Ltd., established on 1997-04-08, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug import and export;Class III medical device business;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Non-residential real estate leases;housing lease;Import and export;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;Financial Advisory;Supply Chain Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Yinfeng Bioengineering Group Co., Ltd., established on 2011-04-19, Business scope includes general items:R&D and application of cell technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Health Consulting Services(Does not include medical services);Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Daily necessities sales;Maternal and baby products sales;Cosmetics Wholesale;Cosmetics Retail.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Health food sales;Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

West China Second University Hospital is a Chinese private company located in Chengdu. The firm provides women and children healthcare services.